Requires instruction in pedestrian and bicyclist safety as part of the drivers pre-licensing course.
Relates to ballots where the express intent of the voter is unambiguous.
Relates to the John R. Lewis Voting Rights Act of New York; establishes rights of actions for denying or abridging the right of any member of a protected class to vote; provides assistance to language-minority groups; provides for preclearance of certain voting policies; makes related provisions.
Relates to reviews by the authorities budget office; grants the authorities budget office the authority to commence an action or special proceeding to annul the corporate existence or dissolve a corporation that has acted beyond its capacity or power; makes related provisions.
Provides a fine of one thousand dollars for a person responsible for a trailer or semitrailer parked or left unattended in a city with a population of one million or more; makes certain exceptions.
Prohibits the use of intoxication of the victim as a defense in sex crimes; creates an affirmative defense where the defendant, at the time he or she engaged in the conduct constituting the offense, did not know of the facts or conditions responsible for such lack of consent.
Relates to providing notice to school districts and nonpublic schools located in a city with a population of one million or more of certain construction projects; requires county superintendents to provide written notice to such school districts and nonpublic schools of certain construction projects undertaken within three hundred feet of a building of such school districts or nonpublic schools.
Excuses prospective jurors who are over the age of 75 or have a health condition putting such person at greater risk for severe illness from COVID-19 from service.
Extends the coverage period for medical assistance to a period of one year beginning on the last day of pregnancy.
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.
